[ U.S. DEPARTMENT OF DEFENSE - Autism Research Program Clinical Translational Research Award | Research funding ]
Event details
| Date | 01.05.2019 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Autism Research Program (ARP) for 2019. The Clinical Translational Research Award supports early-phase, proof-of-principle translational studies that will examine hypothesis-based, innovative interventions that have the potential to address current clinical deficits for ASD. Outcomes from studies funded by this award are anticipated to provide scientific rationale for subsequent development of larger, efficacy-based clinical trials of interventions that will transform ASD clinical care.
Projects are required to involve human subjects. Projects that are strictly animal research aimed at developing or refining new technology and research to establish the efficacy/effectiveness of diagnostic agents are not allowed under this funding opportunity. The proposed studies should include early-phase, proof-of-principle studies using human subjects. The proposed studies may be interventional, including Phase 0 clinical trials or single-group intervention studies, and may involve some retrospective data analysis; however, purely retrospective or database-related research is not allowed.
Applications are strongly encouraged to address one of the ARP Clinical Translational Research Award Areas of Interest. These are listed at the end of this announcement.
Funding: Maximum USD $ 500’000
Duration: 3 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Investigators at the level of Assistant Professor or above are eligible to submit applications.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a list of collaborators and key personnel, a preproposal narrative, and supporting documents as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 01 May 2019, 5:00 p.m. EST (23:00 CET)
Full Application Deadline: 08 August 2018, 11:59 p.m. EST (05:59 09 Aug, CET)
Grants.gov Funding Opportunity Number: W81XWH-19-ARP-CTRA
Further information
FY19 ARP areas of interest:
Projects are required to involve human subjects. Projects that are strictly animal research aimed at developing or refining new technology and research to establish the efficacy/effectiveness of diagnostic agents are not allowed under this funding opportunity. The proposed studies should include early-phase, proof-of-principle studies using human subjects. The proposed studies may be interventional, including Phase 0 clinical trials or single-group intervention studies, and may involve some retrospective data analysis; however, purely retrospective or database-related research is not allowed.
Applications are strongly encouraged to address one of the ARP Clinical Translational Research Award Areas of Interest. These are listed at the end of this announcement.
Funding: Maximum USD $ 500’000
Duration: 3 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Investigators at the level of Assistant Professor or above are eligible to submit applications.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a list of collaborators and key personnel, a preproposal narrative, and supporting documents as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 01 May 2019, 5:00 p.m. EST (23:00 CET)
Full Application Deadline: 08 August 2018, 11:59 p.m. EST (05:59 09 Aug, CET)
Grants.gov Funding Opportunity Number: W81XWH-19-ARP-CTRA
Further information
- To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-19-ARP-CTRA.
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
FY19 ARP areas of interest:
- Behavioral, cognitive, and other non-pharmacological therapies for ASD core symptoms or to alleviate co-occurring conditions
- Pharmacological, genetic, and other biological treatments for ASD core symptoms or to alleviate co-occurring conditions
- Dissemination/implementation of clinically validated interventions
- Improve diagnosis and access to services across the life span
- Interventions promoting success in key transitions to adulthood for individuals living with ASD
- Healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the life span and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief)
- Cultural, socioeconomic, and gender factors in diagnosis, treatment efficacy, delivery, and access to services
Practical information
- General public
- Free